Cargando…

Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience

INTRODUCTION: Human herpesvirus 6 (HHV-6) has been recognized as a potentially significant pathogen in hemopoietic stem cell transplant (HSCT) recipients. Different clinical manifestations have been described, including fever, skin rash, bone marrow suppression, and encephalitis. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dzieciątkowski, Tomasz, Przybylski, Maciej, Torosian, Tigran, Tomaszewska, Agnieszka, Łuczak, Mirosław
Formato:	Texto
Lenguaje:	English
Publicado:	Birkhäuser-Verlag 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766496/ https://www.ncbi.nlm.nih.gov/pubmed/18512026 http://dx.doi.org/10.1007/s00005-008-0021-6

Ejemplares similares

Detection of β-Herpesviruses in Polish Adult Cord Blood Stem Cell Recipients by Real-Time PCR: Single Centre Study
por: Dzieciątkowski, Tomasz, et al.
Publicado: (2010)

Comparison of two methods used for monitoring low-copy cytomegalovirus infection in a patient with chronic myeloid leukemia after unrelated umbilical cord blood transplantation
por: Dzieciątkowski, Tomasz, et al.
Publicado: (2007)

Co-Infections with Cytomegalovirus and Human Herpesvirus Type 7 in Adult Polish Allogeneic Haematopoietic Stem Cell Transplant Recipients
por: Tomaszewska, Agnieszka, et al.
Publicado: (2013)

Simultaneous human herpesvirus 6-associated encephalitis and Guillain-Barré syndrome in a patient after matched unrelated donor haematopoietic stem cell transplantation
por: Tomaszewska, Agnieszka, et al.
Publicado: (2010)

Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Meiqing, et al.
Publicado: (2013)

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)

Prevalence of Herpesvirus DNA in Corneal Transplant Recipients
por: Bu, Julia Bing, et al.
Publicado: (2022)

Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
por: Skoczen, Szymon, et al.
Publicado: (2016)

Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
por: Siemaszko, Jagoda, et al.
Publicado: (2023)

Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
por: Saha, Asim, et al.
Publicado: (2022)

Audit of Psychosocial and Palliative Care Support for Children Having Allogeneic Stem Cell Transplants at the New Zealand National Allogeneic Transplant Centre
por: Evans, Amanda M., et al.
Publicado: (2021)

Current Role of Prospective Monitoring and Preemptive and Prophylactic Therapy for Human Herpesvirus 6 After Allogeneic Stem Cell Transplantation
por: Handley, Guy
Publicado: (2022)

Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation—a single-center analysis
por: Karakulska-Prystupiuk, Ewa, et al.
Publicado: (2021)

Fungal Colonization of the Respiratory Tract in Allogeneic and Autologous Hematopoietic Stem Cell Transplant Recipients: A Study of 573 Transplanted Patients
por: Markowski, Jarosław, et al.
Publicado: (2015)

Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
por: Helbig, Grzegorz, et al.
Publicado: (2019)

Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation
por: Hinterleitner, Martina, et al.
Publicado: (2022)

Prevalence of Pulmonary Infections Caused by Atypical Pathogens in non-HIV Immunocompromised Patients
por: Grabczak, E. M., et al.
Publicado: (2016)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Allogeneic stem cell transplantation for neuroblastoma
por: Sung, Ki Woong
Publicado: (2012)

Infections in Allogeneic Stem Cell Transplantation
por: Pereira, Marcus R., et al.
Publicado: (2018)

Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus
por: Wang, Xin, et al.
Publicado: (2021)

Erratum to: Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia
por: Wilfred, Gilbert, et al.
Publicado: (2022)

Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation
por: Ueda, Miriam YH, et al.
Publicado: (2015)

Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia
por: Razgallah Khrouf, Myriam, et al.
Publicado: (2017)

Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation
por: Kwiecinska, Kinga, et al.
Publicado: (2022)

Regulatory T Cells in Allogeneic Stem Cell Transplantation
por: Michael, Maria, et al.
Publicado: (2013)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Physically “fit” for allogeneic stem cell transplant?
por: Jayani, Reena V., et al.
Publicado: (2021)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Greil, Christine, et al.
Publicado: (2021)

Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016)

Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
por: Hölig, Kristina, et al.
Publicado: (2020)

Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation
por: Rybicka-Ramos, Malwina, et al.
Publicado: (2022)

Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India
por: Khan, Rehan, et al.
Publicado: (2015)

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience
por: Mediwake, Heshani, et al.
Publicado: (2017)

First Ready, First to Go: Ethical Priority-Setting of Allogeneic Stem Cell Transplant at a Major Cancer Centre
por: Bell, Jennifer A.H., et al.
Publicado: (2020)

Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial
por: Hölig, Kristina, et al.
Publicado: (2021)

Human Herpesvirus-6 Encephalitis After Hematopoietic Stem Cell Transplantation
por: Kasberg-Koniarczyk, Heather L.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b890gbdcvfct9lreq5gvqejh7k